1. Home
  2. NTCT vs HCM Comparison

NTCT vs HCM Comparison

Compare NTCT & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetScout Systems Inc.

NTCT

NetScout Systems Inc.

N/A

Current Price

$33.16

Market Cap

2.3B

Sector

Technology

ML Signal

N/A

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

N/A

Current Price

$13.45

Market Cap

2.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NTCT
HCM
Founded
1984
2000
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.3B
IPO Year
1999
2015

Fundamental Metrics

Financial Performance
Metric
NTCT
HCM
Price
$33.16
$13.45
Analyst Decision
Buy
Strong Buy
Analyst Count
2
11
Target Price
★ $42.50
$21.14
AVG Volume (30 Days)
★ 435.5K
37.1K
Earning Date
11-05-2026
07-30-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 125.39
N/A
EPS
★ 0.76
N/A
Revenue
★ $891,820,000.00
N/A
Revenue This Year
$4.76
$14.11
Revenue Next Year
$2.48
$11.97
P/E Ratio
$42.59
★ $5.49
Revenue Growth
N/A
★ N/A
52 Week Low
$25.29
$9.77
52 Week High
$45.28
$16.33

Technical Indicators

Market Signals
Indicator
NTCT
HCM
Relative Strength Index (RSI) 37.65 40.65
Support Level $31.44 $13.00
Resistance Level $34.14 $14.74
Average True Range (ATR) 1.43 0.38
MACD -0.13 -0.10
Stochastic Oscillator 26.99 17.90

Price Performance

Historical Comparison
NTCT
HCM

About NTCT NetScout Systems Inc.

NetScout Systems Inc is engaged in providing enterprise network observability, carrier service assurance, cybersecurity, and Distributed Denial-of-Service (DDoS), protection solutions. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Share on Social Networks: